期刊文献+

细胞周期相关激酶在大肠癌组织中的表达及其意义 被引量:6

Expression and significance of CCRK in colorectal carcinoma
原文传递
导出
摘要 目的探讨细胞周期相关激酶(CCRK)在大肠癌组织中的表达及其与大肠癌临床病理特征之间的关系。方法选取50例经病理学确诊的原发性大肠癌患者的癌组织,以配对的癌旁组织作为对照,采用RT-PCR和Western blot检测CCRK mRNA和CCRK蛋白表达的差异性。结果 CCRK蛋白在大肠癌组织中的阳性率为60.00%(30/50),癌旁结肠组织阳性率为40.00%(20/50)差异有统计学意义(χ2=5.769,P<0.05);CCRK蛋白在大肠癌组织中的相对表达量为2.69±0.87,癌旁组织为1.00±0.28,差异有统计学意义(t=5.81,P<0.05)。CCRK mRNA在大肠癌组织中的阳性率为64.00%,癌旁组织为42.00%,差异有统计学意义(χ2=4.857,P<0.05);CCRK mRNA在大肠癌组织中的相对表达量为2.45±0.92,癌旁组织为1.00±0.21,差异有统计学意义(t=4.83,P<0.05)。PT3-4期大肠癌组织CCRK mRNA阳性率为85.70%(12/14),PT1-2期大肠癌组织阳性率55.56%(20/36),差异有统计学意义(χ2=3.979,P<0.05);PN1-2期大肠癌组织CCRK mRNA阳性率为87.50%(14/16),PN0期为52.94%(18/34),差异有统计学意义(χ2=5.640,P<0.05)。结论 CCRK的高表达与大肠癌发生、发展及其TNM分期有关,检测CCRK蛋白和CCRK mRNA表达可以作为大肠癌早期诊断和预后的一项重要参考指标。 Objective To examine the expression of a cell cycle-related kinase(CCRK)in colorectal cancer tissue and its relationship to the clinicopathological features of colorectal cancer. Methods Subjects were 50 patients who were confirmed by pathology to have primary colorectal cancer.Cancerous tissue from these patients was compared to matching tissue adjacent to the carcinoma.RT-PCR and Western blotting were used to examine differences in expression of CCRK mRNA and protein. Results Colorectal cancer tissue tested positive for expression of the CCRK protein at a rate of 60.00%(30/50)while paracancerous tissue tested positive for expression of the CCRK protein at a rate of(40.00%).The rate of protein expression in those tissues differed significantly(χ2= 5.769,P〈0.05).The relative level of CCRK protein expression in colorectal cancer tissue(2.69±0.87)was significantly higher than that in paracancerous tissue(1.00±0.28,t=5.81,P〈0.05).The rate at which colorectal cancer tissue tested positive for expression of CCRK mRNA(64%)was significantly higher than the rate at which paracancerous tissue tested positive for expression of CCRK mRNA(42%,χ2=4.857,P〈0.05).The relative level of CCRK mRNA expression in colorectal cancer tissue(2.45±0.92)was significantly higher than that in paracancerous tissue(1.00±0.21,t=4.83,P〈0.05).The rate at which PT3-4stage colorectal cancer tissue tested positive for expression of CCRK mRNA(85.7%)was significantly higher than the rate at which PT1-2stage colorectal cancer tissue tested positive for expression of CCRK mRNA(55.6%,χ2=3.979,P〈0.05).The rate at which PN1-2stage colorectal cancer tissue tested positive for CCRK mRNA expression(87.5%)was significantly higher than the rate at which PN0 stage colorectal cancer tissue tested positive for CCRK mRNA expression(52.9%,χ2=5.640,P〈0.05). Conclusion A high level of CCRK expression was associated with the occurrence of colorectal cancer and its TNM stage.Monitoring the expression of the CCRK protein and CCRK mRNA has the potential to be an important indicator for the early diagnosis of colorectal cancer and patient prognosis.
出处 《中国病原生物学杂志》 CSCD 北大核心 2015年第3期228-231,共4页 Journal of Pathogen Biology
基金 山东省医药卫生科技发展计划(No.2013WS0335)
关键词 细胞周期相关激酶 大肠癌 RT-PCR WESTERN BLOT 临床病理 Cell cycle-related kinase colorectal carcinoma RT-PCR Western blotting clinicopathological
  • 相关文献

参考文献12

  • 1Siegel R,Ma J,Zou Z,et al. Cancer statistics,2014[J]. CA Cancer J Clin,2014,64(1): 9-29.
  • 2Qiu H, Dai H, Jain K, et al. Characterization of a novel cardiac iso- form of the cell cycle related kinase that is regulated during heart failure[J]. Biol Chem,2008,283(32) : 22157-65.
  • 3Kaldis P, Solomon MJ. Analysis of CAK activities from human cells [J]. Eur J Biochem,2000,267(13) : 4213-21.
  • 4Wu GQ,Xie D, Yang GF, et al. Cell cycle related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma[J]. Int J Cancer,2009,125(11): 2631-42.
  • 5Yang Y,Hu Y,Gu HY,et al. Oroxylin A induces G2/M phase cell cycle arrest via inhibiting Cdk7 mediated expression of Cdc2/p34 in human gastric carcinoma BGC-823 cells[J]. J Pharm Pharma- col,2008,60(11): 1459-63.
  • 6Krystof V,Uldrijan S. Cyclin-dependent kinase inhibitors as anti- cancer drugs[J].Curr Drug Targets,2010,11(3),291-302.
  • 7W sierska-G dek J, Maurer M. Promotion of apoptosis in cancer cells by selective purine derived pharmacological CDK inhibitors: one outcome, many mechanisms [J]. Curr Pharm Des, 2011,17 (3) : 256-71.
  • 8Farcas R1, Schneider E, Frauenknecht K, et al. Differences in DNA methylation patterns and expression of the CCRK gene in human and nonhuman primate cortices[J]. Mol Biol Evol,2009,26 (6): 1379-89.
  • 9Yang Y, Roine N, Makela TP, et al. CCRK depletion inhibits glio- blastoma cell proliferation in a cilium-dependent manner[J]. EM- BO Rep,2013,14(8) : 741-7.
  • 10Yu Z, Gao YQ, Feng H, et al. Cell cycle-related kinase mediates viral host signalling to promote hepatitis B virus associated hepa toearcinogenesis [J]. Gut,2014,63(11) : 1793-804.

同被引文献62

  • 1Benson AB 3rd, Arnoletti JP, Bekaii-Saab T, et al. Colon cancer [J]. J NatlComprCancNetw,2011, 9(11): 1238--90.
  • 2Bujanda L, Cosme A, Gil I, et al. Malignant eolorectal polyps [J]. WorldJ Gastroenterol, 2010(25): 3103--11.
  • 3Marszalek A, Szylberg L, Wisniewska E, et al. Impact of cox-2, IL-I, TNF-a, IL4 and ILl0 on the process of carcinogenesis in the large bowel[J]. Pol J Pathol, 2012, 63(4): 221 7.
  • 4Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recog- nition of commensal microflora by toll like recertors is required for intestinal homeostasis[J]. Cell, 2004, 118(2) : 229--41.
  • 5Bondurant KL, Lundgrecn A, Herrick JS, ctal. Interleukin genes and associations with colon and rectal cancerrisk and overall survival[J]. Int J? Cancer, 2013, 132(4): 905 15.
  • 6Chung YC, Chang YF. Serum interleukin-6 levels reflect the dis ease statusof colorectal cancer[J]. J Surg Oncol, 2003, 83(4) : 222--6.
  • 7Johansson ME, Gustafsson JK, Holmen-Larsson J, et al. Bacte ria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis[J]. Gut, 2014, 63(2)= 281--91.
  • 8Kang M, Edmundson P, Araujo-Perez F, et al. Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas[J]. BMC Cancer, 2013, 13(1)= 91--7.
  • 9Krzystek-Korpacka M, Diakowska D, Kapturkiewicz B, et al. Profiles of circulating inflammatory cytokines in eolorectal cancer (CRC), high cancer risk conditions, and health are distinct. Pos- sible implications for CRC screening and surveillance[J]. Cancer Lett, 2013,337(1): 107--14.
  • 10Crockett SD, Mott LA, Barry El,, et al. C-reactive protein and risk of colorectal adenomas or serrated a prospective study[J]. Cancer Prey Res, 2014(7) : 1122 7.

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部